Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: sun who wrote (985)	9/23/1999 9:32:00 PM
From: DanZ	Read Replies (2) \| Respond to of 5582

Sun, My answer (guess) for the homework assignment is Novartis. The company makes a smoking cessation gum in Denmark called Nicotinell. Needless to say, this company has a lot of marketing muscle and is ready to take Smith-Kline Beecham on in the smoking cessation market. It is also my belief that the joint venture with GumTech will market nicotine gum as a nicotine delivery system (not smoking cessation). This is a huge opportunity, IMO. nicotinell.de Can you read Danish? lol Here is a description of the company that I found on the Internet. pharma.us.novartis.com Novartis is a world leader in Life Sciences with core businesses in Healthcare, Agribusiness, and Consumer Health (Nutrition and Self-Medication). In 1998 Novartis Group sales were $21.8 billion, of which $12 billion were in Healthcare, $5.8 billion in Agribusiness, and $4 billion in Consumer Health. The group annually invests more than $2.6 billion in research and development. Headquartered in Basel, Switzerland, Novartis group companies employ about 82,000 people and operate in over 140 countries around the world. ___ You made a nice buy on the stock at 11 3/8 today. There is chart support between 11 and 11 1/4, and the buyers were stacked up there on Level II today. I think the stock did very well today given the weakness yesterday and overall weak market today.